$82.57
1.692.09%
At close: -
$80.05
-2.52-3.05%
After Hours: 7:59 PM EDT
Comments
Loading...
Celestica Analyst Ratings and Price Targets | NYSE:CLS | Benzinga
Celestica Inc has a consensus price target of $87.54 based on the ratings of 13 analysts. The high is $160 issued by RBC Capital on February 5, 2025. The low is $14 issued by Citigroup on January 27, 2023. The 3 most-recent analyst ratings were released by CIBC, Stifel, and Barclays on April 15, 2025, February 19, 2025, and February 13, 2025, respectively. With an average price target of $142.33 between CIBC, Stifel, and Barclays, there's an implied 77.81% upside for Celestica Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
CIBC
Stifel
Barclays
RBC Capital
TD Securities
1calculated from analyst ratings
Analyst Ratings for Celestica
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/15/2025 | Buy Now | 49.91% | CIBC | — | $150 → $120 | Maintains | Outperformer | Get Alert |
| 02/19/2025 | Buy Now | 87.38% | Stifel | Matthew Sheerin65% | $140 → $150 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 96.13% | Barclays | George Wang56% | $139 → $157 | Maintains | Overweight | Get Alert |
| 02/05/2025 | Buy Now | 99.88% | RBC Capital | Paul Treiber58% | $140 → $160 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | 74.89% | RBC Capital | Paul Treiber58% | $115 → $140 | Maintains | Outperform | Get Alert |
| 01/30/2025 | Buy Now | 73.64% | Barclays | George Wang56% | $91 → $139 | Maintains | Overweight | Get Alert |
| 01/28/2025 | Buy Now | 33.67% | TD Securities | Daniel Chan71% | $70 → $107 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 43.66% | RBC Capital | Paul Treiber58% | $75 → $115 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 24.92% | Stifel | Matthew Sheerin65% | $70 → $100 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | 18.68% | UBS | David Vogt68% | → $95 | Initiates | → Neutral | Get Alert |
| 11/05/2024 | Buy Now | 13.68% | Barclays | George Wang56% | → $91 | Initiates | → Overweight | Get Alert |
| 10/24/2024 | Buy Now | -12.55% | TD Cowen | Daniel Chan71% | $68 → $70 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -12.55% | Stifel | Matthew Sheerin65% | $58 → $70 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -6.31% | RBC Capital | Paul Treiber58% | $65 → $75 | Maintains | Outperform | Get Alert |
| 10/24/2024 | Buy Now | -10.06% | BMO Capital | Thanos Moschopoulos74% | $64 → $72 | Maintains | Outperform | Get Alert |
| 10/09/2024 | Buy Now | -15.05% | TD Securities | Daniel Chan71% | $61 → $68 | Maintains | Buy | Get Alert |
| 09/09/2024 | Buy Now | -27.55% | Stifel | Matthew Sheerin65% | $58 → $58 | Upgrade | Hold → Buy | Get Alert |
| 07/26/2024 | Buy Now | -27.55% | Stifel | Matthew Sheerin65% | $51 → $58 | Maintains | Hold | Get Alert |
| 07/26/2024 | Buy Now | -25.05% | CIBC | — | $58 → $60 | Maintains | Neutral | Get Alert |
| 07/26/2024 | Buy Now | -12.55% | Canaccord Genuity | Robert Young35% | $53 → $70 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -18.8% | RBC Capital | Paul Treiber58% | $63 → $65 | Maintains | Outperform | Get Alert |
| 06/17/2024 | Buy Now | -21.3% | BMO Capital | Thanos Moschopoulos74% | $53 → $63 | Maintains | Outperform | Get Alert |
| 05/13/2024 | Buy Now | -36.29% | Stifel | Matthew Sheerin65% | $48 → $51 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | -33.79% | RBC Capital | Maxim Matushansky81% | $47 → $53 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | -40.04% | Stifel | Matthew Sheerin65% | $36 → $48 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | -38.79% | CIBC | — | $41 → $49 | Downgrade | Outperform → Neutral | Get Alert |
| 04/22/2024 | Buy Now | -40.04% | BMO Capital | Thanos Moschopoulos74% | $37 → $48 | Maintains | Outperform | Get Alert |
| 03/11/2024 | Buy Now | -30.04% | Cormark Securities | Jesse Pytlak75% | → $56 | Initiates | → Buy | Get Alert |
| 01/31/2024 | Buy Now | -52.53% | RBC Capital | Maxim Matushansky81% | $33 → $38 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | -53.78% | BMO Capital | Thanos Moschopoulos74% | $32 → $37 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | -62.52% | Stifel | Matthew Sheerin65% | $26 → $30 | Maintains | Hold | Get Alert |
| 11/30/2023 | Buy Now | -60.02% | BMO Capital | Thanos Moschopoulos74% | $27 → $32 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | -58.78% | RBC Capital | Maxim Matushansky81% | $30 → $33 | Maintains | Outperform | Get Alert |
| 10/05/2023 | Buy Now | -63.77% | TD Securities | Daniel Chan71% | $23 → $29 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | -62.52% | RBC Capital | Maxim Matushansky81% | $22 → $30 | Maintains | Outperform | Get Alert |
| 09/12/2023 | Buy Now | -72.52% | RBC Capital | Maxim Matushansky81% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 08/16/2023 | Buy Now | -70.02% | Stifel | Matthew Sheerin65% | $20 → $24 | Maintains | Hold | Get Alert |
| 07/28/2023 | Buy Now | -75.02% | Stifel | Matthew Sheerin65% | $14 → $20 | Maintains | Hold | Get Alert |
| 07/28/2023 | Buy Now | -71.27% | TD Cowen | Daniel Chan71% | $14.5 → $23 | Upgrade | Hold → Buy | Get Alert |
| 07/28/2023 | Buy Now | -70.02% | Canaccord Genuity | Robert Young35% | $16 → $24 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | -72.52% | RBC Capital | Maxim Matushansky81% | $14 → $22 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/26/2023 | Buy Now | -82.51% | RBC Capital | Maxim Matushansky81% | → $14 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | -82.51% | RBC Capital | Maxim Matushansky81% | $15 → $14 | Maintains | Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | -81.89% | BMO Capital | Thanos Moschopoulos74% | $15.5 → $14.5 | Maintains | Outperform | Get Alert |
| 04/13/2023 | Buy Now | -81.26% | RBC Capital | Maxim Matushansky81% | → $15 | Reiterates | → Sector Perform | Get Alert |
| 02/23/2023 | Buy Now | -81.26% | RBC Capital | Paul Treiber58% | → $15 | Reiterates | → Sector Perform | Get Alert |
| 01/27/2023 | Buy Now | -82.51% | Citigroup | Jim Suva70% | $12 → $14 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | -80.64% | BMO Capital | Thanos Moschopoulos74% | $14 → $15.5 | Maintains | Outperform | Get Alert |
| 10/26/2022 | Buy Now | -85.01% | Citigroup | Jim Suva70% | $10 → $12 | Maintains | Neutral | Get Alert |
| 10/26/2022 | Buy Now | -85.01% | RBC Capital | Paul Treiber58% | $11 → $12 | Maintains | Sector Perform | Get Alert |
| 08/18/2022 | Buy Now | -82.51% | Argus Research | Kristina Ruggeri44% | → $14 | Upgrade | Hold → Buy | Get Alert |
| 07/27/2022 | Buy Now | -84.38% | BMO Capital | Thanos Moschopoulos74% | $13 → $12.5 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/27/2022 | Buy Now | -87.51% | Citigroup | Jim Suva70% | → $10 | Upgrade | Sell → Neutral | Get Alert |
| 06/06/2022 | Buy Now | -82.51% | Canaccord Genuity | Robert Young35% | $14 → $14 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | -82.51% | Canaccord Genuity | Robert Young35% | $13.5 → $14 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Celestica (CLS) stock?
The latest price target for Celestica (NYSE:CLS) was reported by CIBC on April 15, 2025. The analyst firm set a price target for $120.00 expecting CLS to rise to within 12 months (a possible 49.91% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Celestica (CLS)?
The latest analyst rating for Celestica (NYSE:CLS) was provided by CIBC, and Celestica maintained their outperformer rating.
When was the last upgrade for Celestica (CLS)?
The last upgrade for Celestica Inc happened on September 9, 2024 when Stifel raised their price target to $58. Stifel previously had a hold for Celestica Inc.
When was the last downgrade for Celestica (CLS)?
The last downgrade for Celestica Inc happened on April 26, 2024 when CIBC changed their price target from $41 to $49 for Celestica Inc.
When is the next analyst rating going to be posted or updated for Celestica (CLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celestica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celestica was filed on April 15, 2025 so you should expect the next rating to be made available sometime around April 15, 2026.
Is the Analyst Rating Celestica (CLS) correct?
While ratings are subjective and will change, the latest Celestica (CLS) rating was a maintained with a price target of $150.00 to $120.00. The current price Celestica (CLS) is trading at is $80.05, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.